Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

K Iglay, H Hannachi, P Joseph Howie, J Xu… - … medical research and …, 2016 - Taylor & Francis
Objective: Patients with type 2 diabetes (T2DM) often have multiple comorbidities which may
impact the selection of antihyperglycemic therapies. The purpose of this study was to …
被引用次数：495 相关文章

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

K Iglay, H Hannachi, PJ Howie, J Xu… - Current medical …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective Patients with type 2 diabetes (T2DM) often have multiple comorbidities which may
impact the selection of antihyperglycemic therapies. The purpose of this study was to …

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus.

K Iglay, H Hannachi, J Howie, J Xu, X Li… - Current Medical …, 2016 - europepmc.org
Objective Patients with type 2 diabetes (T2DM) often have multiple comorbidities which may
impact the selection of antihyperglycemic therapies. The purpose of this study was to …

[引用][C] Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

K Iglay, H Hannachi, PJ Howie, J Xu, X Li… - … Medical Research and …, 2016 - cir.nii.ac.jp
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF] academia.edu

[PDF][PDF] Prevalence and Co-prevalence of Comorbidities Among Patients With Type 2 Diabetes Mellitus

K Iglay, H Hannachi, PJ Howie, J Xu, X Li, SS Engel… - 2016 - academia.edu
Objective-Patients with type 2 diabetes (T2DM) often have multiple comorbidities which may
impact the selection of antihyperglycemic therapies. The purpose of this study was to …